Experimental Hematology
Volume 34, Issue 11 , Pages 1532-1541 , November 2006

Insulin and insulin-like growth factor-1 promote mast cell survival via activation of the phosphatidylinositol-3-kinase pathway

  • Eva Lessmann

      Affiliations

    • Department of Molecular Immunology, Biology III, University of Freiburg and Max-Planck-Institute for Immunobiology, Freiburg, Germany
    • ,
  • Gordon Grochowy

      Affiliations

    • Department of Molecular Immunology, Biology III, University of Freiburg and Max-Planck-Institute for Immunobiology, Freiburg, Germany
    • ,
  • Lars Weingarten

      Affiliations

    • Department of Molecular Immunology, Biology III, University of Freiburg and Max-Planck-Institute for Immunobiology, Freiburg, Germany
    • ,
  • Torsten Giesemann

      Affiliations

    • Institute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany
    • ,
  • Klaus Aktories

      Affiliations

    • Institute for Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany
    • ,
  • Michael Leitges

      Affiliations

    • Max Planck Institute for Experimental Endocrinology, Hannover, Germany
    • ,
  • Gerald Krystal

      Affiliations

    • Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    • ,
  • Michael Huber

      Affiliations

    • Department of Molecular Immunology, Biology III, University of Freiburg and Max-Planck-Institute for Immunobiology, Freiburg, Germany
    • Corresponding Author InformationOffprint requests to: Michael Huber, Ph.D., University Freiburg, Department of Molecular Immunology, Biology III, Stuebeweg 51, Freiburg 79108, Germany

Received 25 October 2005 ,Revised 25 May 2006 ,Accepted 26 May 2006.

References 

  1. Costa JJ, Weller PF, Galli SJ. The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA. 1997;278:1815–1822
  2. Turner H, Kinet JP. Signalling through the high-affinity IgE receptor FcɛR1. Nature. 1999;402:B24–B30
  3. Garman SC, Wurzburg BA, Tarchevskaya SS, Kinet JP, Jardetzky TS. Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcɛR1α. Nature. 2000;406:259–266
  4. Ali K, Bilancio A, Thomas M, et al. Essential role for the p110δ phosphoinositide 3-kinase in the allergic response. Nature. 2004;431:1007–1011
  5. Huber M, Helgason CD, Damen JE, Liu L, Humphries RK, Krystal G. The Src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci U S A. 1998;95:11330–11335
  6. Gimborn K, Lessmann E, Kuppig S, Krystal G, Huber M. SHIP down-regulates FcɛR1-induced degranulation at supraoptimal IgE or antigen levels. J Immunol. 2005;174:507–516
  7. Huber M, Helgason CD, Scheid MP, Duronio V, Humphries RK, Krystal G. Targeted disruption of SHIP leads to Steel factor–induced degranulation of mast cells. EMBO J. 1998;17:7311–7319
  8. Vosseller K, Stella G, Yee NS, Besmer P. c-kit receptor signaling through its phosphatidylinositide-3′-kinase-binding site and protein kinase C: role in mast cell enhancement of degranulation, adhesion, and membrane ruffling. Mol Biol Cell. 1997;8:909–922
  9. Tkaczyk C, Horejsi V, Iwaki S, et al. NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and FcɛR1 aggregation. Blood. 2004;104:207–214
  10. Baumann CA, Saltiel AR. Spatial compartmentalization of signal transduction in insulin action. Bioessays. 2001;23:215–222
  11. Decreased prevalence of atopic diseases in children with diabetes. The EURODIAB Substudy 2 Study Group. J Pediatr. 2000;137:470–474
  12. Helander E. Asthma and diabetes. Acta Med Scand. 1958;162:165–174
  13. Carvalho VF, Barreto EO, Cordeiro RS, Lagente V, Martins MA, e Silva PM. Mast cell changes in experimental diabetes: focus on attenuation of allergic events. Mem Inst Oswaldo Cruz. 2005;100(Suppl. 1):121–125
  14. Vianna EO, Garcia-Leme J. Allergen-induced airway inflammation in rats. Role of insulin. Am J Respir Crit Care Med. 1995;151:809–814
  15. Diaz BL, Serra MF, Alves AC, et al. Alloxan diabetes reduces pleural mast cell numbers and the subsequent eosinophil influx induced by allergen in sensitized rats. Int Arch Allergy Immunol. 1996;111:36–43
  16. Cavalher-Machado SC, de Lima WT, Damazo AS, et al. Down-regulation of mast cell activation and airway reactivity in diabetic rats: role of insulin. Eur Respir J. 2004;24:552–558
  17. Karasuyama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol. 1988;18:97–104
  18. Djouder N, Schmidt G, Frings M, Cavalie A, Thelen M, Aktories K. Rac and phosphatidylinositol 3-kinase regulate the protein kinase B in FcɛR1 signaling in RBL 2H3 mast cells. J Immunol. 2001;166:1627–1634
  19. Liu L, Damen JE, Cutler RL, Krystal G. Multiple cytokines stimulate the binding of a common 145-kilodalton protein to Shc at the Grb2 recognition site of Shc. Mol Cell Biol. 1994;14:6926–6935
  20. Lessmann E, Leitges M, Huber M. A redundant role for PKC-ɛ in mast cell signaling and effector function. Int Immunol. 2006;18:767–773
  21. Abramoff M, Magelhaes P, Ram S. Image processing with Image. J Biophot Int. 2004;11:36–42
  22. Kalesnikoff J, Baur N, Leitges M, et al. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-κB activity. J Immunol. 2002;168:4737–4746
  23. Kawakami Y, Nishimoto H, Kitaura J, et al. Protein kinase C βII regulates Akt phosphorylation on Ser-473 in a cell type– and stimulus-specific fashion. J Biol Chem. 2004;279:47720–47725
  24. Clement S, Krause U, Desmedt F, et al. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature. 2001;409:92–97
  25. Scheid MP, Huber M, Damen JE, et al. Phosphatidylinositol(3,4,5)P3 is essential but not sufficient for PKB activation: Phosphatidylinositol(3,4)P2 is required for PKB phosphorylation at Ser473. Studies using cells from SHIP knockout mice. J Biol Chem. 2002;277:9027–9035
  26. White MF. Insulin signaling in health and disease. Science. 2003;302:1710–1711
  27. Welch HC, Coadwell WJ, Stephens LR, Hawkins PT. Phosphoinositide 3-kinase–dependent activation of Rac. FEBS Lett. 2003;546:93–97
  28. Bagrodia S, Taylor SJ, Creasy CL, Chernoff J, Cerione RA. Identification of a mouse p21Cdc42/Rac activated kinase. J Biol Chem. 1995;270:22731–22737
  29. Quinn MT. Low-molecular-weight GTP-binding proteins and leukocyte signal transduction. J Leukoc Biol. 1995;58:263–276
  30. Schirmer J, Aktories K. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins. Biochim Biophys Acta. 2004;1673:66–74
  31. Birkenkamp KU, Coffer PJ, Avruch J, et al. FOXO transcription factors as regulators of immune homeostasis: molecules to die for?. J Immunol. 2003;171:1623–1629
  32. Buchs AE, Rapoport MJ. T cell signaling and autoimmune diabetes. J Pediatr Endocrinol Metab. 2000;13:1549–1554
  33. Avruch J, Khokhlatchev A, Kyriakis JM, et al. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog Horm Res. 2001;56:127–155
  34. Zimmermann S, Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science. 1999;286:1741–1744
  35. Rong R, Ahn JY, Chen P, et al. Phospholipase activity of phospholipase C-γ1 is required for nerve growth factor-regulated MAP kinase signaling cascade in PC12 cells. J Biol Chem. 2003;278:52497–52503
  36. Corbit KC, Soh JW, Yoshida K, Eves EM, Weinstein IB, Rosner MR. Different protein kinase C isoforms determine growth factor specificity in neuronal cells. Mol Cell Biol. 2000;20:5392–5403
  37. Mochly-Rosen D, Gordon AS. Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J. 1998;12:35–42
  38. Ahmad T, Farnie G, Bundred NJ, Anderson NG. The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase. J Biol Chem. 2004;279:1713–1719
  39. Mahadev K, Motoshima H, Wu X, et al. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol Cell Biol. 2004;24:1844–1854
  40. Shatrov VA, Sumbayev VV, Zhou J, Brune B. Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1α (HIF-1α) accumulation via redox-dependent mechanisms. Blood. 2003;101:4847–4849
  41. Huber M, Hughes MR, Krystal G. Thapsigargin-induced degranulation of mast cells is dependent on transient activation of phosphatidylinositol-3 kinase. J Immunol. 2000;165:124–133
  42. Huber M, Kalesnikoff J, Reth M, Krystal G. The role of SHIP in mast cell degranulation and IgE-induced mast cell survival. Immunol Lett. 2002;82:17–21
  43. Hammerman PS, Fox CJ, Thompson CB. Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. Trends Biochem Sci. 2004;29:586–592
  44. Rodriguez-Tarduchy G, Collins MK, Garcia I, Lopez-Rivas A. Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J Immunol. 1992;149:535–540
  45. Moller DE, Yokota A, Caro JF, et al. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol. 1989;3:1263–1269

PII: S0301-472X(06)00396-1

doi: 10.1016/j.exphem.2006.05.022

Experimental Hematology
Volume 34, Issue 11 , Pages 1532-1541 , November 2006

Article Tools

* Image Usage & Resolution